Journal article
The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study
Aimee L Davidson, Uwe Dressel, Sarah Norris, Daffodil M Canson, Dylan M Glubb, Cristina Fortuno, Georgina E Hollway, Michael T Parsons, Miranda E Vidgen, Oliver Holmes, Lambros T Koufariotis, Vanessa Lakis, Conrad Leonard, Scott Wood, Qinying Xu, Amy E McCart Reed, Hilda A Pickett, Mohammad K Al-Shinnag, Rachel L Austin, Jo Burke Show all
Genome Medicine: medicine in the post-genomic era | BMC | Published : 2023
Abstract
Background: Many families and individuals do not meet criteria for a known hereditary cancer syndrome but display unusual clusters of cancers. These families may carry pathogenic variants in cancer predisposition genes and be at higher risk for developing cancer. Methods: This multi-centre prospective study recruited 195 cancer-affected participants suspected to have a hereditary cancer syndrome for whom previous clinical targeted genetic testing was either not informative or not available. To identify pathogenic disease-causing variants explaining participant presentation, germline whole-genome sequencing (WGS) and a comprehensive cancer virtual gene panel analysis were undertaken. Results:..
View full abstractRelated Projects (2)
Grants
Funding Acknowledgements
The authors would like to thank all participants included in this study. We would also like to thank Dr Gillian Mitchell for her expert advice and assistance with helping in establishment of the ICCon project. M.J.M and N.K.P (Adult Genetics Unit, Adelaide) would like to thank their database manager Ms Melissa Paoletti for assistance to identify potentially eligible participants.